FHIR IG analytics

Resources that use this resource

No resources found

Resources that this resource uses

No resources found

Narrative

Note: links and images are rebased to the (stated) source

Source1

{
  "resourceType": "Group",
  "id": "189713",
  "meta": {
    "versionId": "3",
    "lastUpdated": "2026-08-05T07:33:36.353Z"
  },
  "text": {
    "status": "extensions",
    "div": "<!-- snip (see above) -->"
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/artifact-publication-status",
      "valueCodeableConcept": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-status-type",
            "code": "active",
            "display": "Active"
          }
        ]
      }
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/artifact-author",
      "valueContactDetail": {
        "name": "Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter"
      }
    },
    {
      "url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/cite-as",
      "valueMarkdown": "NCT04401202 Eligibility Criteria [Database Entry: FHIR Group Resource]. Contributors: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 189713. Revised 2026-08-05. Available at: https://fevir.net/resources/Group/189713. Computable resource at: https://fevir.net/resources/Group/189713#json."
    }
  ],
  "url": "https://fevir.net/resources/Group/189713",
  "identifier": [
    {
      "type": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/v2-0203",
            "code": "ACSN",
            "display": "Accession ID"
          }
        ],
        "text": "FEvIR Object Identifier"
      },
      "system": "https://fevir.net/FOI",
      "value": "189713",
      "assigner": {
        "display": "Computable Publishing LLC"
      }
    },
    {
      "type": {
        "text": "FEvIR Linking Identifier"
      },
      "system": "https://fevir.net/FLI",
      "value": "NCT04401202 Eligibility Criteria",
      "assigner": {
        "display": "Computable Publishing LLC"
      }
    }
  ],
  "name": "NCT04401202_Eligibility_Criteria",
  "title": "NCT04401202 Eligibility Criteria",
  "status": "active",
  "publisher": "Computable Publishing LLC",
  "contact": [
    {
      "telecom": [
        {
          "system": "email",
          "value": "support@computablepublishing.com"
        }
      ]
    }
  ],
  "description": "Inclusion Criteria:\n* Patients with mild COVID19 upper respiratory tract infection and with no evidence of pneumonia\n* Adult (18 Years and above)\n* Written informed consent prior to initiation of any study procedures by the patient (or legally authorized representative).\n* Understands and agrees to comply with planned study procedures.\n* Has laboratory-confirmed novel coronavirus (SARS-CoV-2) infection as determined by polymerase chain reaction (PCR) available at KAUH.\nExclusion Criteria:\n* Patients with pneumonia or severe illness requiring admission to ICU.\n* Severe chronic kidney disease (i.e. estimated glomerular filtration rate (eGFR) \\< 30) or end stage renal disease requiring dialysis\n* Sever chronic liver disease (Alanine transaminase/aspartate transaminase (ALT/AST) \\> 5 times the upper limit of normal).\n* Pregnancy or breast feeding.\n* Anticipated transfer to another hospital which is not a study site within 72 hours.\n* Allergy to any study medication.",
  "copyright": "Copyright the Authors else Computable Publishing LLC. Noncommercial use permitted with CC BY-NC-SA 4.0 (https://creativecommons.org/licenses/by-nc-sa/4.0/). Commercial use permitted as agreed in Terms of Use (https://fevir.net/termsofuse).",
  "membership": "conceptual",
  "combinationMethod": "all-of",
  "characteristic": [
    {
      "code": {
        "text": "Defined by CodeableConcept"
      },
      "valueCodeableConcept": {
        "text": "Patients with mild COVID19 upper respiratory tract infection and with no evidence of pneumonia"
      },
      "exclude": false,
      "description": "Patients with mild COVID19 upper respiratory tract infection and with no evidence of pneumonia"
    },
    {
      "code": {
        "text": "Defined by CodeableConcept"
      },
      "valueCodeableConcept": {
        "text": "Adult (18 Years and above)"
      },
      "exclude": false,
      "description": "Adult (18 Years and above)"
    },
    {
      "code": {
        "text": "Defined by CodeableConcept"
      },
      "valueCodeableConcept": {
        "text": "Written informed consent prior to initiation of any study procedures by the patient (or legally authorized representative)."
      },
      "exclude": false,
      "description": "Written informed consent prior to initiation of any study procedures by the patient (or legally authorized representative)."
    },
    {
      "code": {
        "text": "Defined by CodeableConcept"
      },
      "valueCodeableConcept": {
        "text": "Understands and agrees to comply with planned study procedures."
      },
      "exclude": false,
      "description": "Understands and agrees to comply with planned study procedures."
    },
    {
      "code": {
        "text": "Defined by CodeableConcept"
      },
      "valueCodeableConcept": {
        "text": "Has laboratory-confirmed novel coronavirus (SARS-CoV-2) infection as determined by polymerase chain reaction (PCR) available at KAUH."
      },
      "exclude": false,
      "description": "Has laboratory-confirmed novel coronavirus (SARS-CoV-2) infection as determined by polymerase chain reaction (PCR) available at KAUH."
    },
    {
      "code": {
        "text": "Defined by CodeableConcept"
      },
      "valueCodeableConcept": {
        "text": "Patients with pneumonia or severe illness requiring admission to ICU."
      },
      "exclude": true,
      "description": "Patients with pneumonia or severe illness requiring admission to ICU."
    },
    {
      "code": {
        "text": "Defined by CodeableConcept"
      },
      "valueCodeableConcept": {
        "text": "Severe chronic kidney disease (i.e. estimated glomerular filtration rate (eGFR) \\< 30) or end stage renal disease requiring dialysis"
      },
      "exclude": true,
      "description": "Severe chronic kidney disease (i.e. estimated glomerular filtration rate (eGFR) \\< 30) or end stage renal disease requiring dialysis"
    },
    {
      "code": {
        "text": "Defined by CodeableConcept"
      },
      "valueCodeableConcept": {
        "text": "Sever chronic liver disease (Alanine transaminase/aspartate transaminase (ALT/AST) \\> 5 times the upper limit of normal)."
      },
      "exclude": true,
      "description": "Sever chronic liver disease (Alanine transaminase/aspartate transaminase (ALT/AST) \\> 5 times the upper limit of normal)."
    },
    {
      "code": {
        "text": "Defined by CodeableConcept"
      },
      "valueCodeableConcept": {
        "text": "Pregnancy or breast feeding."
      },
      "exclude": true,
      "description": "Pregnancy or breast feeding."
    },
    {
      "code": {
        "text": "Defined by CodeableConcept"
      },
      "valueCodeableConcept": {
        "text": "Anticipated transfer to another hospital which is not a study site within 72 hours."
      },
      "exclude": true,
      "description": "Anticipated transfer to another hospital which is not a study site within 72 hours."
    },
    {
      "code": {
        "text": "Defined by CodeableConcept"
      },
      "valueCodeableConcept": {
        "text": "Allergy to any study medication."
      },
      "exclude": true,
      "description": "Allergy to any study medication."
    }
  ]
}